Cite
HARVARD Citation
Yutani, S. et al. (2015). Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients. Journal of immunology research. p. . [Online].